Article
WHO, Wyeth partner on phase I drug trial
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Oral zervimesine reduced GA lesion growth in phase 2 study from Cognition Therapeutics
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Innovent Biologics completes first patient dosing in its phase 2 clinical trial assessing efdamrofusp alfa in patients with DME
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Assessment of AI-enabled screening for ROP in low-resource settings
First patient dosed in VAN-2401 phase 1 clinical trial